Breaking News Instant updates and real-time market news.

TRVN

Trevena

$6.03

0.11 (1.86%)

13:00
10/19/16
10/19
13:00
10/19/16
13:00

Trevena's Gowen says migraine drug on track

  • 22

    Oct

  • 13

    Dec

TRVN Trevena
$6.03

0.11 (1.86%)

03/02/16
WBTH
03/02/16
INITIATION
Target $18
WBTH
Buy
Trevena initiated with a Buy at WallachBeth
WallachBeth analyst Caroline Palomeque started Trevena with a Buy rating and $18 price target. The company's lead candidate Oliceridine for post-operative acute pain may offer patients a treatment option with comparable analgesic efficacy, a faster onset of action and a more favorable safety profile than morphine, Palomeque tells investors in a research note.
03/02/16
03/02/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chemical Financial (CHFC) initiated with a Strong Buy at Raymond James by analyst David Long, who believes its pending accretive merger with Talmer Bancorp (TLMR) will provide the base for a more profitable company with strengthened growth prospects. 2. Infinity Pharmaceuticals (INFI) initiated with an Outperform at FBR Capital, with analyst Christopher James saying that duvelisib has the potential to be a first-in-class treatment for specific types of blood cancers. 3. Trevena (TRVN) initiated with a Buy at WallachBeth by analyst Caroline Palomeque, who said Oliceridine may offer patients a treatment option with comparable analgesic efficiency, a faster onset of action and a more favorable safety profile than morphine. 4. Aduro Biotech (ADRO) initiated with an Outperform at FBR Capital. 5. LKQ Corp. (LKQ) initiated with a Buy at Sterne Agee CRT. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/16
FBRC
03/29/16
INITIATION
Target $16
FBRC
Outperform
Trevena initiated with an Outperform at FBR Capital
FBR Capital analyst Christopher James started Trevena with an Outperform rating and $16 price target.
05/17/16
ROTH
05/17/16
NO CHANGE
Target $14.5
ROTH
Buy
Roth Capital remains a buyer of Trevena
Roth Capital analyst Michael Higgins reiterates a Buy rating and $14.50 price target on Trevena's shares. The analyst says the company announced that its TRV027 failed in Phase 2 and will be discontinuing the program. However, given the relative risk of development between its oliceridine and its TRV027, Higgins is not making any changes to his financial models. Trevena is "well-capitalized," with cash sufficient to fund operations for two years, the analyst tells investors in a research note, adding that he sees the company's shares as being at an "attractive entry point."

TODAY'S FREE FLY STORIES

14:20
09/26/17
09/26
14:20
09/26/17
14:20
Conference/Events
FBN Securities strategist to hold an analyst/industry conference call »

Chief Market Strategist…

BLK

BlackRock

$434.46

-3.17 (-0.72%)

14:20
09/26/17
09/26
14:20
09/26/17
14:20
Options
Far upside call buyer in Blackrock opens a notable new position »

Far upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

SYT

Syngenta

$92.07

-0.01 (-0.01%)

14:18
09/26/17
09/26
14:18
09/26/17
14:18
Hot Stocks
Syngenta reports pending settlement to resolve corn litigation »

Plaintiffs and defendants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
09/26/17
09/26
14:17
09/26/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/26/17
09/26
14:16
09/26/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$48.42

0.1 (0.21%)

14:10
09/26/17
09/26
14:10
09/26/17
14:10
Options
Delta calls outpace puts 10:1 as a bullish spread is opened »

Delta calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

, UNH

UnitedHealth

$192.38

0.63 (0.33%)

14:09
09/26/17
09/26
14:09
09/26/17
14:09
Periodicals
GOP agrees not to vote on healthcare bill, CNN reports »

Senate Majority Leader…

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

UNH

UnitedHealth

$192.38

0.63 (0.33%)

CNC

Centene

$92.15

1.82 (2.01%)

WCG

WellCare

$165.88

1.7305 (1.05%)

CI

Cigna

$183.10

1.66 (0.91%)

ANTM

Anthem

$183.18

1.68 (0.93%)

HNT

Health Net

HUM

Humana

$239.83

2.62 (1.10%)

AET

Aetna

$153.66

1.6785 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 17

    Oct

  • 24

    Oct

  • 08

    Nov

FL

Foot Locker

$34.77

0.11 (0.32%)

14:05
09/26/17
09/26
14:05
09/26/17
14:05
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$88.48

0.27 (0.31%)

13:58
09/26/17
09/26
13:58
09/26/17
13:58
Hot Stocks
American Express raises quarterly dividend 9% to 35c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 18

    Oct

  • 22

    Oct

FIT

Fitbit

$6.49

0.045 (0.70%)

13:57
09/26/17
09/26
13:57
09/26/17
13:57
Hot Stocks
Fitbit to participate in FDA software pilot program »

Fitbit announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

FB

Facebook

$162.87

-7.67 (-4.50%)

, WMT

Wal-Mart

$79.48

0.33 (0.42%)

13:51
09/26/17
09/26
13:51
09/26/17
13:51
Hot Stocks
Wal-Mart to roll out Workplace by Facebook »

Julien Codorniou, the VP…

FB

Facebook

$162.87

-7.67 (-4.50%)

WMT

Wal-Mart

$79.48

0.33 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 08

    Oct

  • 10

    Oct

  • 22

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

PTEN

Patterson-UTI

$20.47

0.94 (4.81%)

13:50
09/26/17
09/26
13:50
09/26/17
13:50
Options
Put buyers active in Patterson Energy »

Put buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.87

-7.67 (-4.50%)

, SLF

Sun Life Financial

$39.46

0.19 (0.48%)

13:49
09/26/17
09/26
13:49
09/26/17
13:49
Hot Stocks
Sun Life Financial announces launch of Workplace by Facebook »

Sun Life Financial (SLF)…

FB

Facebook

$162.87

-7.67 (-4.50%)

SLF

Sun Life Financial

$39.46

0.19 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 03

    Oct

  • 08

    Oct

  • 22

    Oct

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

, WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

13:46
09/26/17
09/26
13:46
09/26/17
13:46
Recommendations
e.l.f. Beauty, Walgreens Boots Alliance analyst commentary  »

e.l.f. Beauty products…

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

13:45
09/26/17
09/26
13:45
09/26/17
13:45
General news
Fed funds futures slid lower on the heels of Yellen's comments »

Fed funds futures slid…

SRCI

SRC Energy

$9.18

0.36 (4.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Options
Call writer opens a notable new position in SRC Energy as shares outperform »

Call writer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 16

    May

HMNY

Helios and Matheson

$8.30

1.33 (19.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Periodicals
Helios and Matheson mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDP

Meredith

$54.05

-0.35 (-0.64%)

13:31
09/26/17
09/26
13:31
09/26/17
13:31
Hot Stocks
Meredith names Alysia Borsa chief marketing and data officer »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWP

Boardwalk Pipeline

$14.95

0.1734 (1.17%)

13:30
09/26/17
09/26
13:30
09/26/17
13:30
Options
In the money call buying continues in Boardwalk Pipeline »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
09/26/17
09/26
13:30
09/26/17
13:30
General news
More from Yellen: not much new in her Q&A, reiterating the two sided risks »

More from Yellen: not…

NKE

Nike

13:29
09/26/17
09/26
13:29
09/26/17
13:29
Periodicals
Nike: Code left company over 3 years ago, no longer an employee, Bloomberg says »

Merl Code, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

13:20
09/26/17
09/26
13:20
09/26/17
13:20
General news
Treasury Action: yields steadied below highs »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
09/26/17
09/26
13:17
09/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
09/26/17
09/26
13:16
09/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$58.49

-0.06 (-0.10%)

13:15
09/26/17
09/26
13:15
09/26/17
13:15
Conference/Events
Target management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.